Elan Pharmaceuticals subsidiary signs consent decree with FDA.

0 Comments | M2 Presswire, May, 2001

M2 PRESSWIRE-22 May 2001-US FDA: Elan Pharmaceuticals subsidiary signs consent decree with FDA (C)1994-2001 M2 COMMUNICATIONS LTD RDATE:21052001 FDA today announced that Elan Holdings, Inc. a wholly-owned subsidiary of Elan Corporation plc of County Westmeath, Ireland, has signed a consent decree of permanent injunction setting forth measures to assure that the firms Gainesville, Georgia manufacturing facility fully complies with FDAs good manufacturing practice (GMP) requirements.

Also signing the consent decree were Donal J. Geaney, Chairman and Chief Executive Officer of Elan Corporation plc and President of Elan Holdings, Inc., William C. Clark, President of Elan Pharmaceutical Operations, Hal Herring, Vice President and General Manager of Elan...